Proteome SciencesPMSNF Receivables Turnover is 3.07 as of Dec. 2025. The stock has 6 warning signs investors should review. Among 202 Medical Diagnostics & Research companies, Proteome Sciences ranks better than 75.25% on this metric.
The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. Proteome Sciences's Revenue for the
six
months ended in Dec. 2025 was $2.54 Mil. Proteome Sciences's average Accounts Receivable for the
six
months ended in Dec. 2025 was $0.83 Mil.
Hence, Proteome Sciences's Receivables Turnover for the
six
months ended in Dec. 2025 was 3.07.
An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.
Proteome Sciences Receivables Turnover Related Terms
Proteome Sciences Receivables Turnover Historical Data
* Premium members only.
The historical data trend for Proteome Sciences's Receivables Turnover can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PMSNF vs TMO, DHR, IDXX: Receivables Turnover Comparison
For the Diagnostics & Research subindustry, Proteome Sciences's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Proteome Sciences Receivables Turnover vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Proteome Sciences's Receivables Turnover distribution charts can be found below:
* The bar in red indicates where Proteome Sciences's Receivables Turnover falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Proteome Sciences (PMSNF) has a Receivables Turnover of 3.07 as of Dec. 2025. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on Proteome Sciences and its competitors. According to the industry distribution chart, Proteome Sciences ranks #50 out of 202 companies in the Medical Diagnostics & Research industry, placing it in the top 24.8%.
Is Proteome Sciences' Receivables Turnover too high?
Proteome Sciences' current Receivables Turnover is 3.07. The Medical Diagnostics & Research industry median Receivables Turnover is 5.38. Proteome Sciences' value of 3.07 is 42.9% below this industry median. Based on the distribution chart, Proteome Sciences ranks #50 out of 202 companies in the Medical Diagnostics & Research industry, which is in the top quartile — a strong position relative to peers.
How does Proteome Sciences' Receivables Turnover compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, Proteome Sciences ranks #50 out of 202 companies for Receivables Turnover. This places Proteome Sciences in the top 25% of its industry — outperforming the majority of peers. The industry median Receivables Turnover is 5.38. Proteome Sciences' value of 3.07 is 42.9% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Receivables Turnover for a Medical Diagnostics & Research company?
The median Receivables Turnover among Medical Diagnostics & Research companies is 5.38, based on 202 companies in the industry. Companies in the top quartile (top 25%) have a Receivables Turnover significantly above this median, while those in the bottom quartile fall well below. However, Receivables Turnover should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Proteome Sciences's current Receivables Turnover of 3.07 is 42.9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Receivables Turnover mean?
A high Receivables Turnover can signal that a stock is expensive relative to its fundamentals. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on Proteome Sciences and its competitors. For the Medical Diagnostics & Research industry, the median Receivables Turnover is 5.38 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Proteome Sciences's current Receivables Turnover is 3.07. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Proteome Sciences stock overvalued right now?
Proteome Sciences (PMSNF) has a current Receivables Turnover of 3.07. The stock's GF Value™ is $0.03, compared to a current price of $0.02 — trading 17.5% below its estimated fair value. The current Receivables Turnover is 3.07 and 42.9% below the Medical Diagnostics & Research industry median of 5.38. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Receivables Turnover calculated?
Receivables Turnover is calculated from a company's financial statements. For Proteome Sciences (PMSNF), the current Receivables Turnover is 3.07 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Proteome Sciences PLC is engaged in protein biomarker research and development. The company is a provider of contract research services for the identification, validation and application of protein biomarkers. The company's only reportable segment is the sale of goods and biomarker services. The company generates maximum revenue from the TMT product and end customer sales-based royalties. Geographically, it has a presence in the United States, the United Kingdom, the European Union, and Others.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
PMSNF has been successfully added to your 